ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
US Tech 100
19,460.00
0.95%
Dow Jones
39,331.85
0.41%
Brent Oil
86.555
0.13%
Bitcoin
60,859.84
-1.88%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Celadon Pharmaceuticals Plc (CEL) Quote

Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc (CEL)

Challenger Gold Limited
75.00
-2.50
(-3.23%)
Closed July 02 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
75.00
Bid
73.00
Ask
77.00
Volume
23,427
75.00 Day's Range 77.50
67.50 52 Week Range 160.00
Market Cap
49.487M
Previous Close
77.50
Open
77.50
Last Trade
1500
@
74
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
55,525
Shares Outstanding
65,982,712
Dividend Yield
-
PE Ratio
-6.93
Earnings Per Share (EPS)
-0.11
Revenue
149k
Net Profit
-7.14M

About Celadon Pharmaceuticals Plc

Sector
Investment Advice
Industry
Investment Advice
Website
celadonpharma.co.uk
Headquarters
London, Gbr
Founded
1970
Celadon Pharmaceuticals Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 77.50p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 67.50p to 160.00p.

Celadon Pharmaceuticals currently has 65,982,712 shares outstanding. The market capitalization of Celadon Pharmaceuticals is £49.49 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.93.

CEL Latest News

More News

Celadon Pharmaceuticals PLC Result of AGM

Celadon Pharmaceuticals PLC 28 June 2024     Celadon Pharmaceuticals Plc   ("Celadon" or the "Company")   Result of Annual General Meeting   London, UK, 28 June 2024: Celadon Pharmaceuticals...

June 28 2024
RNS Regulatory News

Celadon Pharmaceuticals PLC Second Admission of Shares

Celadon Pharmaceuticals PLC 07 June 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company" or the "Group")   Second Admission of Shares   London, 07 June 2024 - Celadon...

June 07 2024
RNS Regulatory News

...

June 03 2024
Alliance News

Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM

Celadon Pharmaceuticals PLC 03 June 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company")    Publication of Annual Report and Notice of Annual General Meeting   London, 3 June...

June 03 2024
RNS Regulatory News

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

May 23 2024
Alliance News

Celadon Pharmaceuticals PLC Supply of Products to New US Customer

Celadon Pharmaceuticals PLC 23 May 2024     Celadon Pharmaceuticals Plc   ("Celadon", or the "Company")   Supply of Cannabis-Based Products to New US Customer London, 23 May 2024 - Celadon...

May 23 2024
RNS Regulatory News

Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights

Celadon Pharmaceuticals PLC 15 May 2024     Celadon Pharmaceuticals Plc   ("Celadon", or the "Company")   Exercise of Share Options and Total Voting Rights   London, 15 May 2024 - Celadon...

May 15 2024
RNS Regulatory News

TRADING UPDATES: Headlam warns of loss; EnSilica predicts revenue rise

The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

May 14 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.5-3.2258064516177.579752295878.33827719DE
4-12.5-14.285714285787.587.567.56430679.41365871DE
12-12.5-14.285714285787.512067.55552593.76316697DE
26-40-34.782608695711512067.54218894.2604259DE
52-72.5-49.1525423729147.516067.532800102.01542771DE
156-115-60.5263157895190190494653699.36153175DE
260-24-24.2424242424993304950207133.25431469DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RDZNRoadzen Inc
$ 2.95
(82.10%)
107.99M
SYTSYLA Technologies Company Ltd
$ 3.05
(59.69%)
6.19M
VSVersus Systems Inc
$ 1.90
(43.94%)
58.92M
VIVKVivakor Inc
$ 3.41
(36.95%)
727.57k
MEDSTRxADE HEALTH Inc
$ 18.585
(30.70%)
397.65k
MAXNMaxeon Solar Technologies Ltd
$ 0.18
(-67.20%)
173.82M
RNACCartesian Therapeutics Inc
$ 15.7715
(-35.02%)
1.45M
EFTReFFECTOR Therapeutics Inc
$ 0.18
(-32.56%)
1.62M
DTSSDatasea Inc
$ 3.43
(-30.57%)
1.15M
ARDXArdelyx Inc
$ 5.29
(-30.12%)
22.66M
NVDANVIDIA Corporation
$ 122.67
(-1.31%)
220.35M
TSLATesla Inc
$ 231.26
(10.20%)
205.03M
MAXNMaxeon Solar Technologies Ltd
$ 0.18
(-67.20%)
173.82M
SQQQProShares UltraPro Short QQQ
$ 7.88
(-2.96%)
114.55M
RDZNRoadzen Inc
$ 2.95
(82.10%)
107.99M

Discussion

View Full Feed
The Night Stalker The Night Stalker 3 minutes ago
in time
HADV
TheFinalCD TheFinalCD 3 minutes ago
https://www.youtube.com/watch?v=J0QLpkiZ3K0
BTCUSD
halbroke1 halbroke1 3 minutes ago
NNAX $$$ THOSE THAT SOLD TODAY, FOR NO GOOD REASON HAVE NO BRI*ANS, VERY UNNECESSARY !!!...WATCH THE HUGE REBOUND TOMORROW !!!! MOON-ROCKET..
NNAX
bbotcs bbotcs 4 minutes ago
lj: I wish China would put tariffs on U.S. oranges. Since they started importing them, the price of a California orange is ridiculous--$1 an orange. This week I bought a bag of oranges from Morocco, of all places. Not a lot of taste but very juicy.
Patient Ninja Patient Ninja 4 minutes ago
Tommy keeps filing and appears to be up to date. Check it out on OTCM.
CCTL
demonsmith demonsmith 5 minutes ago
If they get 500k member that 185 mil year just from membership
SMCE
rooster rooster 5 minutes ago
I don’t know what Hunter Biden is telling them he wants for heath care
bbotcs bbotcs 6 minutes ago
lj: TSLA allegedly is having a rebound rally. Stopped following the stock, knowing that this one is good for trades. Haven't done any options on it since last October, I believe. Time to start paying attention.
TSLA
stevhoff stevhoff 6 minutes ago
Ok thanks for that info. But still they don't have the cash to pay the accumulated preferred divs and it would take a few years to pay that off at the rate they're going. I just stay away from form 15 companies, at any time they could choose to go dark if they wanted. I hope it works out for you. I
cojoboy cojoboy 6 minutes ago
Is he gone...????
RONN
stevhoff stevhoff 6 minutes ago
Ok thanks for that info. But still they don't have the cash to pay the accumulated preferred divs and it would take a few years to pay that off at the rate they're going. I just stay away from form 15 companies, at any time they could choose to go dark if they wanted. I hope it works out for you. I
Menace212 Menace212 9 minutes ago
‘Form NT also requires management to explain the reason for the late filing and declare whether it expects to subsequently file within the allowed grace period’

They released the NT on 4/01.

‘RespireRx Pharmaceuticals Inc. (the “Registrant”) was unable, without unreason
RSPI
ignatiusrielly35 ignatiusrielly35 10 minutes ago
Be careful with your praise of ANVS. Your cubicle mate might have been assigned to bash it. It could get awkward around the water cooler.
ANVS
The Great Pumpkin The Great Pumpkin 10 minutes ago
You know what’s even worse. It’s in a ROTH. This clown could have sold and paid no taxes and bought back if they ever became a viable solution for the industry. Remember this is the person you are taking advice from, a complete loser. SMH. I’ve warned you all the way down from at least $15. You can’
SMH
NorthPeak22 NorthPeak22 13 minutes ago
In his opinion, Cain said the government’s decision to halt approvals appears to be “completely without reason or logic and is perhaps the epiphany of ideocracy.”

Nice to see some sanity from the courts.
TGLO
Firefly67 Firefly67 14 minutes ago
Did the unanimous jury win get appealed by the FHFA?
FNMA
SSKILLZ1 SSKILLZ1 14 minutes ago
Well am I wrong. He was 0-4 again today and is hitting 180 with under a 500 ops. That is worse than jeff mcniel, trust me that is a guy I keep begging the manager to sit everyday, instead he can't even execute a sacrifice bunt against a reliever in the 10th who got destroyed by pretty much everyone
jaiguruji7 jaiguruji7 14 minutes ago
Hi LP, I agree with what you have said, your predictions have come true. But below are some things that I wanted to add/bring up, regarding your "Next PREDICTIONS" , let me know your thoughts and analysis. Other longs are also welcome to comment and point out their analysis.

Next PR
DBMM
blackhawks blackhawks 14 minutes ago
Good points. And all of that evidence will be fodder for Cable news and even, I suppose, the NYT's editorial board.
The Great Pumpkin The Great Pumpkin 14 minutes ago
Going to be hilarious seeing X as the mayor of penny town again after all these years. Unreal he let those paper gains go. Terrible terrible terrible.

#scam
LWLG
TRAPPER JIM TRAPPER JIM 15 minutes ago
I’ll get there. It’s just a slow process
StayHumble StayHumble 15 minutes ago
NewRULES WILL LEAD T0 SHORT SQUEEZE HAV0K✅per Charles Gasparino on the new CAT system 🟩🟩🟩
$DBMM $GME $GTII $HCMC $UBQU
https://youtu.be/OU2Qdvb-ZZM
DBMM GME GTII

Your Recent History

LSE
CEL
Celadon Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved